High Content Screening

Evotec uses the Opera™ confocal cell imaging device to identify and characterize active compounds in novel, information-rich, cell-based assays.

Benefits of Evotec’s high content screening offering:

Opera™offers the highest available resolution through confocal technology with four laser sources and a throughput of up to 200,000 images per day
Ability to carry out cell-based assays for targets that are typically screened enzymatically (e.g. kinases) and thus identify hits in a cellular context earlier
The ability to undertake pathway and phenotypic screening will help identify novel chemical matter for intractable targets
The readout multiplexing capabilities facilitated by the Opera™ reader assists in reducing false positives, false negatives and provides information on multiple targets and cellular events
The platform is compatible with the use of primary and stem cells

For more information, please contact us at info@evotec.com